Aytu BioPharma to Present at Upcoming September 2025 Conferences
-
UK's Starmer mulling 'political realities': senior minister
-
England's Stokes and Atkinson withdrawn from county games ahead of 3rd Test
-
France presses ahead with music festivals despite extreme heat
-
Ukrainian strikes on Russian-annexed Crimea kill 4, pause fuel sales
-
Springboks recall 'outstanding' Papier for Nations Championship
-
US, Iran set for talks as Lebanon conflict threatens deal
-
Bezzecchi out of Czech MotoGP after slapping steward
-
Spain target convincing win to dispel World Cup doubts
-
FIFA draws criticism as Infantino clocks up air miles at World Cup
-
Curacao keeper Room jokes he deserves statue after World Cup heroics
-
Japan stroll to victory over Tunisia in World Cup's 1,000th game
-
Pakistan's mango exports shrink as Middle East war impacts linger
-
Trump blames 'terrible vandals' for Washington pool renovation woes
-
Iran World Cup travel restrictions to be eased, says coach
-
Man charged over suspected anti-Muslim attacks in Edinburgh
-
Room heroics earn Curacao World Cup point against Ecuador
-
Britain's King Charles to reveal personal tax bill: reports
-
New mindset, prior win give Clark confidence at US Open
-
Fly-half Love ready for All Blacks start after Super Rugby heroics
-
Scheffler eager to seize the moment as career slam beckons
-
Saudis seek to repeat Argentina World Cup 'miracle' against Spain
-
Clark leads by six at US Open as Scheffler charges
-
Nagelsmann says Germany has higher ambitions than advancing to knockout stage
-
Los Angeles under state of emergency due to warehouse fire
-
US and Iran set for new talks after delay and deadly strikes
-
'Fired up' Spain ready to hit back, says De la Fuente
-
Germany into World Cup last 32 after late comeback, Dutch thrash Sweden
-
Germany come from behind to beat Ivory Coast and reach World Cup last 32
-
Albanian protests against Trump-linked resort swell
-
Clark clings to US Open lead as Scheffler charges
-
Burn dons cowboy boots as England unwind at World Cup
-
Miotti kicks Montpellier past Stade Francais into Top 14 final
-
France's Saliba says playing through the pain at World Cup
-
Iran says Hormuz closed as US-Iran deal falters over Lebanon
-
Counter-terror cops probe suspected anti-Muslim 'attacks' in Edinburgh
-
Bagnaia scorches to Czech MotoGP sprint victory, Bezzecchi suspended
-
Clark begins with bogey as McIlroy charges at US Open
-
Bolivia declares state of emergency, deploys military to quell protests
-
Specter of military escalation hangs over Colombia vote
-
Heavy metal: French town hosts medieval combat cage fights
-
Jamieson strikes as New Zealand eye series-levelling win despite Root heroics
-
Dutch swat Sweden as Germany, Ivory Coast eye World Cup knockout rounds
-
Netherlands thump Sweden in Houston to get World Cup liftoff
-
Scheffler opens with bogeys while McIlroy pars at windy US Open
-
Jamieson strikes as New Zealand eye series-levelling win against England
-
Brazil turn corner but tougher World Cup tests await
-
Ronaldinho coming out of retirement to join Italian 3rd division side
-
Cerundolo sees off Nakashima to set up Queen's final with Paul
-
Real Madrid say no contact with Bayern's Olise
-
Fritz takes down Zverev again to reach Halle final
Aytu BioPharma to Present at Upcoming September 2025 Conferences
DENVER, CO / ACCESS Newswire / September 24, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced management will participate at the following investor conferences:
MicroCap Rodeo Fall Conference
Date: Thursday, September 25, 2025
Location: New York City
Presentation Time: 2:00 p.m. Eastern time
Webcast: https://www.webcaster5.com/Webcast/Page/3142/53024
Lytham Partners Fall 2025 Investor Conference
Date: Tuesday, September 30, 2025
Location: Virtual
Presentation Time: 2:45 p.m. Eastern time
Webcast: https://app.webinar.net/K8vDlaelmAd
Management will be participating in one-on-one meetings throughout both events. To arrange a meeting with management, please contact Robert Blum of Lytham Partners at [email protected].
About Aytu BioPharma
Aytu is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. The Company's prescription products include EXXUA™ (gepirone) extended-release tablets (see Full Prescribing Information, including Boxed WARNING) for the treatment of major depressive disorder (MDD), Adzenys XR-ODT® (amphetamine) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING) and Cotempla XR-ODT® (methylphenidate) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING) for the treatment of attention deficit hyperactivity disorder (ADHD), and a line of legacy products, including Karbinal® ER (carbinoxamine maleate), Poly-Vi-Flor® and Tri-Vi-Flor®. To learn more, please visit aytubio.com.
Contacts for Investors
Ryan Selhorn, Chief Financial Officer
Aytu BioPharma, Inc.
[email protected]
Robert Blum
Lytham Partners
[email protected]
SOURCE: Aytu BioPharma, Inc.
View the original press release on ACCESS Newswire
A.Clark--AT
